Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists
about
Elevated levels of procoagulant microparticles in a patient with myocardial infarction, antiphospholipid antibodies and multifocal cardiac thrombosisRole of Platelet-Derived Microvesicles As Crosstalk Mediators in Atherothrombosis and Future Pharmacology Targets: A Link between Inflammation, Atherosclerosis, and ThrombosisProthrombotic markers and early spontaneous recanalization in ST-segment elevation myocardial infarctionCD235a (Glycophorin-A) Is the Most Predictive Value Among Different Circulating Cellular Microparticles in Thrombocytopenic Human Immunodeficiency Virus Type 1.Acetylsalicylate reduces endothelial and platelet-derived microparticles in patients with coronary artery disease.Microparticles: major transport vehicles for distinct microRNAs in circulation.Circulating annexin V positive microparticles in patients after successful cardiopulmonary resuscitationRole of microparticles in atherothrombosis.Microvesicles are messengers.Pharmacology of antiplatelet agents.Renewal of mural thrombus releases plasma markers and is involved in aortic abdominal aneurysm evolution.Extracellular vesicles in coronary artery disease.Endothelial microparticles act as novel diagnostic and therapeutic biomarkers of circulatory hypoxia-related diseases: a literature review.Antiplatelet therapy: current strategies and future trends.Circulating microparticles from diabetic rats impair endothelial function and regulate endothelial protein expression.A Meta-Analysis of Circulating Microvesicles in Patients with Myocardial Infarction.Effect of abciximab on the levels of circulating microparticles in patients with acute myocardial infarction treated by primary angioplasty.Correlation and association between plasma platelet-, monocyte- and endothelial cell-derived microparticles in hypertensive patients with type 2 diabetes mellitus.Platelet-derived microparticle levels are significantly elevated in patients treated by elective stenting compared to subjects with diagnostic catheterization alone.Increased soluble glycoprotein V concentration during the acute onset of unstable angina pectoris in association with chronic cigarette smoking.The Impact of Vascular Disease Treatment on Platelet-Derived Microvesicles.Microvesicles in Atherosclerosis and Angiogenesis: From Bench to Bedside and Reverse.Microvesicles as Emerging Biomarkers and Therapeutic Targets in Cardiometabolic Diseases.Initiation and Propagation of Vascular Calcification Is Regulated by a Concert of Platelet- and Smooth Muscle Cell-Derived Extracellular Vesicles.
P2860
Q24816944-2F61F317-308C-49B9-AB58-F57EEB382CD7Q28069254-D3FF4BEB-5E53-41B7-8D3F-34582D7A714BQ28220222-7A9BD177-5A39-40C9-97C0-45425D36D00CQ33420727-82B78D11-FA5A-422C-B256-0D497148D762Q33888658-75516723-5F1C-4A3D-A072-38E94F90659DQ35792749-F5901355-E0A9-4CF1-B0B3-D31B6936CB1EQ35908304-25F4437A-B4A2-4049-B1A1-458A049055F9Q37138036-132FA103-2F7B-42BC-ABF9-C28EA7C6067EQ37876768-B3E0D2FD-9CD4-4CBF-8B06-66D0D809864BQ38154211-9D5D2BCC-6975-441A-853C-8328D8C33E7BQ38622747-9ECC9378-7881-4C47-8001-20684DD33645Q39115035-29849233-D04E-4110-ADE2-FDA5C3291F73Q39186270-31302447-440D-40BD-9329-EADB5585EA47Q40329892-A40B48B3-D3A9-4D4A-B54E-9F2C4090EA85Q40667685-848A0928-88CA-4527-A294-ADA169A2B72FQ41556597-4EACECF1-166F-4026-AD0A-392B1B301585Q41765654-ED7B868E-1819-41D9-B545-CA502A92A105Q43297937-523236DF-7E36-43F2-B6A8-B8CC65AF1561Q46670831-FA7D547F-E65F-4698-A53B-935B4DC097C4Q46728497-FEE3DEE3-597E-4A80-B72B-8FDD400F3A76Q47159100-9CFB3BD9-2C95-47AF-BC55-E366AD0BCF2EQ49741768-785A2649-8704-4214-BA60-405D11329EEDQ49807920-D5707214-F00F-4F48-A563-5F6597E16FBEQ52571055-0F611558-7EB2-4CD2-8F4A-E0373EAB32A9
P2860
Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Circulating procoagulant micro ...... ole for GPIIb-IIIa antagonists
@ast
Circulating procoagulant micro ...... ole for GPIIb-IIIa antagonists
@en
Circulating procoagulant micro ...... ole for GPIIb-IIIa antagonists
@nl
type
label
Circulating procoagulant micro ...... ole for GPIIb-IIIa antagonists
@ast
Circulating procoagulant micro ...... ole for GPIIb-IIIa antagonists
@en
Circulating procoagulant micro ...... ole for GPIIb-IIIa antagonists
@nl
prefLabel
Circulating procoagulant micro ...... ole for GPIIb-IIIa antagonists
@ast
Circulating procoagulant micro ...... ole for GPIIb-IIIa antagonists
@en
Circulating procoagulant micro ...... ole for GPIIb-IIIa antagonists
@nl
P2093
P3181
P1476
Circulating procoagulant micro ...... ole for GPIIb-IIIa antagonists
@en
P2093
J-M Freyssinet
J-P Cazenave
M-P Douchet
P2860
P304
P3181
P356
10.1111/J.1538-7836.2004.00805.X
P407
P577
2004-07-01T00:00:00Z